208 participants
Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-19
- Start Date:
- 2023-06-14
- Completion:
- 2024-11-30
Conditions
- Rheumatoid Arthritis
Interventions
- DRUG
No Results Yet